Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Incentivizing Lifestyle Modification to Reduce Disease Burden
Status: Enrolling
Updated:  11/17/2016
Lubbock Dream Center
mi
from
Lubbock, TX
Incentivizing Lifestyle Modification to Reduce Disease Burden
Status: Enrolling
Updated: 11/17/2016
Lubbock Dream Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Columbia University
mi
from
New York, NY
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Wake Forest University
mi
from
Winston-Salem, NC
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Veterans Affairs
mi
from
Memphis, TN
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Veterans Affairs
mi
from
Memphis, TN
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Univ of Washington
mi
from
Seattle, WA
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
McMaster University
mi
from
Hamilton,
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
McMaster University
mi
from
Hamilton,
Click here to add this to my saved trials
Study of ACCS (Amnion-derived Cellular Cytokine Solution) in Diabetic Subjects With Deep Burns Managed With Skin Grafts
A Phase 2a Randomized, Double Blind, Placebo Controlled, Single-center Study of ACCS (Amnion-derived Cellular Cytokine Solution) Spray in Diabetic Subjects With Deep Burns Managed With Meshed Skin Grafts.
Status: Enrolling
Updated:  11/29/2016
The Burn Unit of the Wexner Medical Center at The Ohio State University.
mi
from
Columbus, OH
Study of ACCS (Amnion-derived Cellular Cytokine Solution) in Diabetic Subjects With Deep Burns Managed With Skin Grafts
A Phase 2a Randomized, Double Blind, Placebo Controlled, Single-center Study of ACCS (Amnion-derived Cellular Cytokine Solution) Spray in Diabetic Subjects With Deep Burns Managed With Meshed Skin Grafts.
Status: Enrolling
Updated: 11/29/2016
The Burn Unit of the Wexner Medical Center at The Ohio State University.
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Anniston, AL
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Anniston, AL
Click here to add this to my saved trials
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Miami, FL
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Orlando, FL
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Baton Rouge, LA
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Minneapolis, MN
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Parktown,
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
An Adaptive Design Study for the Assessment of the Pharmacokinetics of Albiglutide in Subjects With Normal Renal Function and Subjects With Moderate-to-severe Renal Impairment and Hemodialysis.
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Parktown,
Click here to add this to my saved trials
A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Austin, TX
A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Drug Interaction Study of Albiglutide and Digoxin
An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Albiglutide in Healthy Adult Subjects
Status: Enrolling
Updated:  11/30/2016
GSK Investigational Site
mi
from
Austin, TX
A Drug Interaction Study of Albiglutide and Digoxin
An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Digoxin When Coadministered With Albiglutide in Healthy Adult Subjects
Status: Enrolling
Updated: 11/30/2016
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus
Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  12/1/2016
David Grant USAF Medical Center
mi
from
Travis AFB, CA
Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus
Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/1/2016
David Grant USAF Medical Center
mi
from
Travis AFB, CA
Click here to add this to my saved trials
Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome
Role of Cardiac CT in Risk Factor Control in Asymptomatic Patients With Diabetes
Status: Enrolling
Updated:  12/7/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome
Role of Cardiac CT in Risk Factor Control in Asymptomatic Patients With Diabetes
Status: Enrolling
Updated: 12/7/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Metabolomic Profiling of Novel Mediators of Vascular Function
Metabolomic Profiling of Novel Mediators of Vascular Function
Status: Enrolling
Updated:  12/8/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Metabolomic Profiling of Novel Mediators of Vascular Function
Metabolomic Profiling of Novel Mediators of Vascular Function
Status: Enrolling
Updated: 12/8/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control
Status: Enrolling
Updated:  12/14/2016
Temple University School of Podiatric Medicine Gait Study Center
mi
from
Philadelphia, PA
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control: a Pilot Study
Dynamic Plantar Microvascular Skin Response to Compressive Loads in At-risk Diabetic and Healthy Control
Status: Enrolling
Updated: 12/14/2016
Temple University School of Podiatric Medicine Gait Study Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
Mechanisms of Reduced Ramipril on the Onset of Type 2 Diabetes Mellitis
Status: Enrolling
Updated:  12/20/2016
University of Maryland, Baltimore
mi
from
Baltimore, MD
Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
Mechanisms of Reduced Ramipril on the Onset of Type 2 Diabetes Mellitis
Status: Enrolling
Updated: 12/20/2016
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Santa Barbara, CA
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Basal/Bolus Therapy for Patients With Gestational Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Birmingham, AL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Mobile, AL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Phoenix, AZ
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Tucson, AZ
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Loma Linda, CA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Long Beach, CA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Sacramento, CA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
San Diego, CA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Englewood, CO
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Englewood, CO
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Hartford, CT
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Hartford, CT
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
New Haven, CT
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Gainesville, FL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Miami, FL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Orlando, FL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Pensacola, FL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Pensacola, FL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Tallahassee, FL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Tampa, FL
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Atlanta, GA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Idaho Falls, ID
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Indianapolis, IN
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Iowa City, IA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Baton Rouge, LA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
New Orleans, LA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Baltimore, MD
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Boston, MA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated:  12/21/2016
Novo Nordisk Investigational Site
mi
from
Worcester, MA
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
Basal/Bolus Therapy With Insulin Aspart (NovoLog®) Versus Regular Human Insulin (Novolin® R) or Insulin Lispro (Humalog®) in Combination With NPH: An Open-Label, Randomized, Parallel Group, Multicenter Study in Children and Adolescents With Type 1 Diabetes
Status: Enrolling
Updated: 12/21/2016
Novo Nordisk Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials